Shields Advanced Therapies Revenue

Hospitals and Health Care • • 1-10 Employees

Shields Advanced Therapies revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues	$2,500,000
Total funding	No funding

Key Contacts at Shields Advanced Therapies

Jack Shields

Founder & Chairman

Nicholas R. Adams

Sr. Director, Cell & Gene Therapy Program Operations

Max Kosoy

Senior Director Product Access

Ali Setian

Director, Strategy & Operations

Sarah Spina

Director Of Clinical Operations

Company overview

Headquarters	XX
Website	shieldsadvancedtherapies.com
NAICS	62
Founded	2024
Employees	1-10

Shields Advanced Therapies Email Formats

Shields Advanced Therapies uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@shieldsat.com), used 100% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@shieldsat.com	100%

About Shields Advanced Therapies

Shields Advanced Therapies partners with health systems to accelerate advanced therapy access and operations, ensuring lifechanging breakthroughs reach more patients. Our management services and technology solutions serve as a horizontal support hub to empower health system-led, world-class advanced therapy care across 50+ disease states. Launched in September 2024, Shields Advanced Therapies is anchored by partnerships with four of the Top 20 Academic Medical Centers in the United States. Additionally, Shields' track record partnering with over 1,000 hospitals across 43 states in prior ventures provides a national channel for expansion.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Entry

Founder/Owner

Employees by Department

Shields Advanced Therapies has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Shields Advanced Therapies has never raised funding before.

Frequently asked questions

Shields Advanced Therapies is located in XX.

Shields Advanced Therapies generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.

Shields Advanced Therapies has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Shields Advanced Therapies was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Shields Advanced Therapies has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.